FOR INVESTORS

Disease outmatched by the science of degradation

FOR INVESTORS

FOR INVESTORS

Nurix is a clinical-stage biopharmaceutical company advancing targeted protein degradation as the next frontier in drug development.

Events

Minimum 15 minutes delayed. Source: LSEG

June 08, 2026

Report of unscheduled material events or corporate event

June 02, 2026

Filed by "insiders" prior intended sale of restricted stock.

June 02, 2026

Statement of changes in beneficial ownership of securities